ImmunoBiology Ltd Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2015
NCT02572635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

ImmunoBiology Limited | Sponsor (ImmunoBiology Ltd)